Month: January 2026

FAT Brands’ Charitable Organization Fights Hunger for the Holiday Season LOS ANGELES, Jan. 23, 2026 (GLOBE NEWSWIRE) — The FAT Brands Foundation, the charitable arm of FAT (Fresh. Authentic. Tasty.) Brands Inc., a leading global franchising company that owns restaurant brands including Johnny Rockets, Fatburger, Round Table Pizza, and 15 other concepts, is pleased to announce it raised over $15,000 through its holiday giving campaign, helping Feeding America®, the nation’s leading hunger-relief organization, to provide meals to people experiencing food insecurity “As part of the restaurant community, food insecurity is a cause of great importance to us,” said Jessica Wiederhorn, President of FAT Brands Foundation. “Our network of supporters truly delivered—from the corporate team, vendors, franchisees, and more. The impact that...

ANCHORAGE, Alaska, Jan. 23, 2026 (GLOBE NEWSWIRE) — Northrim BanCorp, Inc. (NASDAQ:NRIM) (“Northrim” or the “Company”) today reported net income of $12.4 million, or $0.55 per diluted share, in the fourth quarter of 2025, compared to $27.1 million, or $1.20 per diluted share, in the third quarter of 2025, and $10.9 million, or $0.49 per diluted share, in the fourth quarter a year ago. The decrease in the fourth quarter of 2025 compared to the third quarter of 2025 is primarily the result of the third quarter gain from the sale of certain assets by Pacific Wealth Advisors of $14.2 million. Additionally, in the fourth quarter of 2025 the Company had an increase in other operating expenses mostly due to performance-related increases in salaries and other personnel expense and marketing expense. The increase in marketing expense is...

Dallas, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2025 financial results on Thursday, February 26th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation related to the call will be accessible from the “Investors” section of Enovis’ website at www.enovis.com. Conference Call/Webcast Information Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link...

ASUS continues to demonstrate its global competitiveness through acknowledged excellence in innovation, social responsibility, and product quality KEY POINTSConsistent Excellence: 11th inclusion on Fortune’s World’s Most Admired Companies list, recognizing company’s innovativeness, product quality, and moreDesign Thinking Ethos: Accolade highlights the ASUS commitment to user-centricity, prioritizing customer satisfaction to drive growth and deliver real valueUbiquitous AI. Incredible Possibilities: ASUS provides a comprehensive AI ecosystem that offers unparalleled performance and a dedication to sustainabilityTORONTO, Jan. 23, 2026 (GLOBE NEWSWIRE) — ASUS today announced its eleventh inclusion on Fortune’s World’s Most Admired Companies list for 2026. This prestigious accolade recognizes the company’s consistent...

FORT MYERS, Fla., Jan. 23, 2026 (GLOBE NEWSWIRE) — Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that the Company will release financial results for the first quarter ended December 31, 2025, on Wednesday, February 4, 2026 after market close. The Company will host a conference call to discuss its financial results on Thursday, February 5, 2026, at 8:30 am Eastern Time. Interested parties may join the conference call by dialing 1-800-245-3047 in the United States and 1-203-518-9765 from outside of the United States. The participant identification to join the conference call is ALICO. A telephone replay will be available on Thursday, February 5, 2026 approximately three hours after the call concludes, and will be available through Thursday, February 19, 2026. Listeners in the United States may dial 1-844-512-2921...

SINGAPORE, Jan. 23, 2026 (GLOBE NEWSWIRE) — GCL Global Holdings Ltd. (NASDAQ: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced it will host a conference call to discuss its first half fiscal year 2026 results on Friday, January 30, 2026, at 8:00 a.m. EST. The earnings release and related investor deck will be available prior to the event in the “Financial Results” section under “Financials”, while the live webcast will be available on the investor relations homepage and in the “Events” section under the “News & Events” header on the investor relations website at ir.gclglobalholdings.com. For participants who wish to dial in to the conference, please register in advance using the link provided below and dial in 10 to 15 minutes prior to the call. Dial-in numbers, passcode and unique...

Extension Reinforces Stran’s Leadership in Large-Scale Experiential and Branded Merchandise Program Quincy, MA, Jan. 23, 2026 (GLOBE NEWSWIRE) — Stran & Company, Inc. (“Stran” or the “Company”) (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, announced that it has signed a three-year, multimillion-dollar contract extension with a premier nonprofit running organization. This customer is one of the most recognized community-based running organizations globally, annually producing dozens of adult and youth races as well as hosting one of the world’s largest and most prestigious marathons, attracting tens of thousands of participants. The organization is widely known for its mission-driven approach...

THE WOODLANDS, Texas, Jan. 23, 2026 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will ring the Nasdaq Stock Market Closing Bell on Tuesday, January 27, 2026. The event will commemorate Lexicon’s 30th anniversary as a biopharmaceutical company building a differentiated pipeline of oral small-molecule therapies for people living with serious cardiometabolic diseases and chronic neuropathic pain. “In its early days, Lexicon was focused on pioneering a deeper understanding of the human genome – today, we’ve leveraged that strong scientific foundation to support a compelling pipeline, including late-stage opportunities and commercially available medication,” said Mike Exton, Ph.D., chief executive officer and director of Lexicon. “For 30 years, Lexicon has brought forward medical research...